A pivotal study has demystified the genetic underpinnings of schaftoside, a vital compound in traditional Chinese medicine (TCM) with significant potential as a COVID-19 therapeutic. The research decodes the biosynthetic pathway and uncovers gene expansions within the Grona styracifolia genome, providing critical insights for optimizing the production of this promising medicinal agent.